Renal Cancer - Results from #700

Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment. October 9, 2023

Identification of KIFC1 as an independent prognostic marker in renal clear cell carcinoma correlates with tumor proliferation and immune infiltration. October 6, 2023

Cellular specificity of lactate metabolism and a novel lactate-related gene pair index for frontline treatment in clear cell renal cell carcinoma. October 6, 2023

Effect of Stereotactic Body Radiotherapy on the Growth Kinetics and Enhancement Pattern of Primary Renal Tumors. October 6, 2023

Diagnostic miRNA Signatures in Paired Tumor, Plasma, and Urine Specimens From Renal Cell Carcinoma Patients. October 5, 2023

Systemic Treatment for Advanced and Metastatic Non-Clear Cell Renal Cell Carcinoma: Examining Modern Therapeutic Strategies for a Notoriously Challenging Malignancy. October 5, 2023

Evaluation of Volumetric Response Assessment from Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Carcinoma (RCC). October 4, 2023

Outcomes of Targeted Therapy Plus Immunotherapy and High-Dose Stereotactic Ablative Body Radiotherapy (SABR) for Metastatic Renal Cell Cancer Patients. October 4, 2023

5-Year Renal Function Outcomes after SABR for Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium of the Kidney (IROCK). October 4, 2023

Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites. October 3, 2023

Predicting Peri-Operative Outcomes in Patients Treated with Percutaneous Thermal Ablation for Small Renal Masses: The SuNS Nephrometry Score. October 3, 2023

Exosomes in the Diagnosis and Treatment of Renal Cell Cancer. October 2, 2023

A novel coagulation-related lncRNA predicts the prognosis and immune of clear cell renal cell carcinoma. October 2, 2023

Robot-Assisted Renal Surgery with the New Hugo Ras System: Trocar Placement and Docking Settings. September 29, 2023

Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives. September 29, 2023

Nuclear speckles regulate HIF-2α programs and correlate with patient survival in kidney cancer. September 28, 2023

Potential value of mitochondrial regulatory pathways in the clinical application of clear cell renal cell carcinoma: a machine learning-based study. September 28, 2023

Pharmacist-Urologist Collaborative Management for Patients with Renal Cell Carcinoma Receiving Pazopanib Monotherapy. September 27, 2023

Systemic Inflammatory Biomarkers Predict Survival of Patients Treated With Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma. September 27, 2023

PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors. September 26, 2023

Page 36 of 456